Future developments in hormonal contraception.

Area of Science:

• Reproductive Health
• Pharmacology
• Women's Health

Background:

• Oral contraceptives (OCs) are the most popular reversible birth control method in the US.
• A significant percentage of unintended pregnancies occur in women using contraception.
• There is a need for improved contraceptive compliance and effectiveness.

Purpose of the Study:

• To review recent advancements in contraceptive options.
• To highlight the benefits of new long-term and combined hormonal contraceptives.
• To discuss the potential impact of these new methods on contraceptive compliance and effectiveness.

Main Methods:

• Review of recently approved contraceptive formulations in the United States and Europe.
• Comparison of new contraceptive methods with existing options, including oral contraceptives.
• Focus on hormonal contraceptives delivered via various methods (oral, patch, ring, injectable, intrauterine system, implant).

Main Results:

• Newer contraceptive options include transdermal patches, monthly vaginal rings, combination injectables, and levonorgestrel-releasing intrauterine systems.
• These methods offer advantages such as once-weekly dosing, user control, improved bleeding control, and reduced menstrual blood loss.
• Combined hormonal contraceptives show effectiveness and safety profiles comparable to traditional OCs.
• A subdermal implant is approved for use in Europe.

Conclusions:

• The expanding range of contraceptive options, including long-acting reversible contraceptives and combined hormonal methods, offers enhanced compliance and effectiveness.
• These advancements provide more personalized and suitable birth control choices for individual users.
• Increased accessibility to diverse and effective contraceptive methods can potentially reduce unintended pregnancies.